Literature DB >> 30792349

Role for nuclear interleukin-37 in the suppression of innate immunity.

Suzhao Li1, Jesus Amo-Aparicio2, Charles P Neff1, Isak W Tengesdal1,3, Tania Azam1, Brent E Palmer1, Rubèn López-Vales2, Philip Bufler4, Charles A Dinarello5,3.   

Abstract

The IL-1 family member IL-37 broadly suppresses innate inflammation and acquired immunity. Similar to IL-1α and IL-33, IL-37 is a dual-function cytokine in that IL-37 translocates to the nucleus but also transmits a signal via surface membrane receptors. The role of nuclear IL-37 remains unknown on the ability of this cytokine to inhibit innate inflammation. Here, we compared suppression of innate inflammation in transgenic mice expressing native human IL-37 (IL-37Tg) with those of transgenic mice carrying the mutation of aspartic acid (D) to alanine (A) at amino acid 20 (IL-37D20ATg). The mutation D20A prevents cleavage of caspase-1, a step required for IL-37 nuclear translocation. In vitro, peritoneal macrophages from IL-37Tg mice reduced LPS-induced IL-1β, IL-6, TNFα and IFNγ by 40-50% whereas in macrophages from IL-37D20ATg mice this suppression was not observed, consistent with loss of nuclear function. Compared with macrophages from IL-37Tg mice, significantly less or no suppression of LPS-induced MAP kinase and NFκB activation was also observed in macrophages from IL-37D20ATg mice. In vivo, levels of IL-1β, IL-6, and TNFα in the lungs and liver were markedly reduced during endotoxemia in IL-37Tg mice but not observed in IL-37D20ATg mice. However, suppression of innate inflammation remains intact in the IL-37D20A mice once the cytokine is released from the cell and binds to its receptor. These studies reveal a nuclear function for suppression of innate inflammation and are consistent with the dual function of IL-37 and a role for caspase-1 in limiting inflammation.

Entities:  

Keywords:  IL-37; caspase-1; inflammation; mutation; suppression

Mesh:

Substances:

Year:  2019        PMID: 30792349      PMCID: PMC6410848          DOI: 10.1073/pnas.1821111116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  The interleukin-1 receptor family.

Authors:  Diana Boraschi; Aldo Tagliabue
Journal:  Vitam Horm       Date:  2006       Impact factor: 3.421

2.  Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice.

Authors:  Qingchun Zeng; Rui Song; David A Fullerton; Lihua Ao; Yufeng Zhai; Suzhao Li; Dov B Ballak; Joseph C Cleveland; T Brett Reece; Timothy A McKinsey; Dingli Xu; Charles A Dinarello; Xianzhong Meng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

3.  IL-37 suppresses MyD88-mediated inflammatory responses in human aortic valve interstitial cells.

Authors:  Qiong Zhan; Qingchun Zeng; Rui Song; Yufeng Zhai; Dingli Xu; David A Fullerton; Charles A Dinarello; Xianzhong Meng
Journal:  Mol Med       Date:  2017-03-27       Impact factor: 6.354

Review 4.  LPS induction of gene expression in human monocytes.

Authors:  M Guha; N Mackman
Journal:  Cell Signal       Date:  2001-02       Impact factor: 4.315

5.  A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity.

Authors:  Philip Bufler; Tania Azam; Fabia Gamboni-Robertson; Leonid L Reznikov; Sanjay Kumar; Charles A Dinarello; Soo-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

6.  Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells.

Authors:  Yuchun Luo; Xiangna Cai; Sucai Liu; Sen Wang; Claudia A Nold-Petry; Marcel F Nold; Philip Bufler; David Norris; Charles A Dinarello; Mayumi Fujita
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-07       Impact factor: 11.205

7.  Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation.

Authors:  Idan Cohen; Peleg Rider; Yaron Carmi; Alex Braiman; Shahar Dotan; Malka R White; Elena Voronov; Michael U Martin; Charles A Dinarello; Ron N Apte
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

Review 8.  Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Theoharis C Theoharides
Journal:  Eur J Pharmacol       Date:  2017-09-29       Impact factor: 4.432

9.  Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37.

Authors:  Frank L van de Veerdonk; Mark S Gresnigt; Marije Oosting; Jos W M van der Meer; Leo A B Joosten; Mihai G Netea; Charles A Dinarello
Journal:  Front Microbiol       Date:  2015-01-07       Impact factor: 5.640

10.  OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.

Authors:  Carlo Marchetti; Benjamin Swartzwelter; Fabia Gamboni; Charles P Neff; Katrin Richter; Tania Azam; Sonia Carta; Isak Tengesdal; Travis Nemkov; Angelo D'Alessandro; Curtis Henry; Gerald S Jones; Scott A Goodrich; Joseph P St Laurent; Terry M Jones; Curtis L Scribner; Robert B Barrow; Roy D Altman; Damaris B Skouras; Marco Gattorno; Veronika Grau; Sabina Janciauskiene; Anna Rubartelli; Leo A B Joosten; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

View more
  14 in total

1.  IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin.

Authors:  Irene Tsilioni; Arti B Patel; Harry Pantazopoulos; Sabina Berretta; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

Review 2.  Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases.

Authors:  Xinrui Li; Bing Yan; Jin Du; Shanshan Xu; Lu Liu; Caifei Pan; Xianhui Kang; Shengmei Zhu
Journal:  Brain Sci       Date:  2022-05-31

Review 3.  Interleukins in cancer: from biology to therapy.

Authors:  Daria Briukhovetska; Janina Dörr; Stefan Endres; Peter Libby; Charles A Dinarello; Sebastian Kobold
Journal:  Nat Rev Cancer       Date:  2021-06-03       Impact factor: 69.800

Review 4.  IL-1 Family Members in Cancer; Two Sides to Every Story.

Authors:  Kevin J Baker; Aileen Houston; Elizabeth Brint
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

5.  IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.

Authors:  Alba Sánchez-Fernández; Stephanie Zandee; Jesús Amo-Aparicio; Marc Charabati; Alexandre Prat; Cecilia Garlanda; Elan Z Eisenmesser; Charles A Dinarello; Rubèn López-Vales
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 6.  The Effect of Unconventional Cytokine Combinations on NK-Cell Responses to Viral Infection.

Authors:  David E Ochayon; Stephen N Waggoner
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 8.786

7.  Extracellular and nuclear roles of IL-37 after spinal cord injury.

Authors:  Jesus Amo-Aparicio; Alba Sanchez-Fernandez; Suzhao Li; Elan Z Eisenmesser; Cecilia Garlanda; Charles A Dinarello; Ruben Lopez-Vales
Journal:  Brain Behav Immun       Date:  2020-09-28       Impact factor: 7.217

Review 8.  Current Understanding of IL-37 in Human Health and Disease.

Authors:  Zhangci Su; Xiaoan Tao
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

9.  Plasma Interleukin-37 is Elevated in Acute Ischemic Stroke Patients and Probably Associated With 3-month Functional Prognosis.

Authors:  Feng Zhang; Tianrui Zhu; Heng Li; Yi He; Yuanyuan Zhang; Nana Huang; Guitao Zhang; Yanshuang Li; Dujuan Chang; Xiaohong Li
Journal:  Clin Interv Aging       Date:  2020-08-04       Impact factor: 4.458

Review 10.  Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection.

Authors:  Ashleigh R Murphy-Schafer; Silke Paust
Journal:  Front Cell Infect Microbiol       Date:  2021-02-19       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.